Table 2 Number of exacerbation episodes
TreatmentNo of patients analysed*Exacerbations/patient** (95% CI)p Value
Months 1–6
Budesonide1150.32 (0.22 to 0.46)
DSCG601.24 (0.95 to 1.63)<0.001
Months 7–18
Bud/Bud570.97 (0.70 to 1.34)
Bud/placebo (Budesonide as needed)581.69 (1.31 to 2.18)
DSCG511.58 (1.20 to 2.08)
Bud/Bud vs Bud/placebo0.008
Bud/Bud vs DSCG0.023
Bud/placebo vs DSCG0.728
  • *The total effective number of patients analysed. **The mean number of exacerbations divided by the number of patients in the group. Bud, budesonide.